Grants and Contributions:
Title:
Determining In Vitro and In Vivo Absorption and Flow Diversion Characteristics of a Novel Bioabsorbable Stent for Aneurysms.
Agreement Number:
955222
Agreement Value:
$100,000.00
Agreement Date:
Aug 1, 2020 - Apr 30, 2021
Description:
For this IRAP project proposal, we will leverage our recently awarded MITACS funding to complete research and development studies on the absorption and flow diversion characteristics of our novel self-expandable bioabsorbable stent.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2L 1Y8
Reference Number:
172-2020-2021-Q2-955222
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
707314092
Recipient Type:
For-profit organization
Recipient's Operating Name:
Fluid Biotech Inc.
Recipient's Legal Name:
Fluid Biotech Inc.
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3391